Loading the security page…
The series is stated in the current share scale after splits; dividends are not included in the price
Artivion, Inc. (AORT) is a public company in the healthcare sector. Its common stock trade on NYSE.
Over the trailing twelve months as reported to 2025-12-31, revenue was 441.3m $, net income was 9.8m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Artivion, Inc. (AORT) is a company in the Health care sector; its shares trade on NYSE.
The price of Artivion, Inc. (AORT) on October 30, 2026 is 21.85 $, −6.78 % on the day. Over 52 weeks the stock traded between 19.16 $ and 48.25 $; the price now sits 9 % of the way up that range. Over the past year the price changed by −47.34 %. Market capitalization is 1.08 billion $, rank 32 among 100 stocks of the same industry with a known capitalization.
Artivion, Inc. trades on NYSE under the ticker AORT. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks AORT has traded between 19.16 $ and 48.25 $. As of 30 October 2026 the price stood 9.32 % of the way from the 52-week low to the high.
Over one year AORT shares fell 47.34 %; over six months they fell 40.47 %. Volatility over 90 days is 42.23 %. Dividends are not included: this is price change only, as of 30 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 2.3, below the sector median of 3.6. Price to book is 2.4, below the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
Artivion, Inc. reported revenue of 471M $ and a net loss of 3M $ over the last four quarters. Net margin is −0.67 %. Revenue changed by +16.40 % year over year. Earnings per share are −0.06 $. Market capitalisation is 1.1B $.
AORT has a return on equity of −0.71 %, above the sector median of −40.58 %. Return on assets is −0.30 %, above the sector median of −30.08 %. Operating margin is 4.38 %, above the sector median of −20.96 %.